NJNerea Jimenez-Tellez

Nerea Jimenez-Tellez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nerea Jimenez-Tellez has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Δ 9 -THC Promotes Profibrotic Cell States In Vitro and Impairs Vascular Function In Vivo

    by Nerea Jimenez-Tellez, Francesca Vacante, Themistoklis M. Tsarouchas, Cody Juguilon, Alberto Casas-Ortiz, Mark Chandy, Tzu-Tang Wei, Joseph C. Wu

  • NEREA: a versatile computer vision-based software for analyzing angiogenesis

    by Nerea Jimenez-Tellez, Alberto Casas-Ortiz, Francesca Vacante, Xiaochun Yang, Carlos Obejero-Paz, Joseph C Wu

  • The relationship between cannabis and cardiovascular disease: clearing the haze

    by Mark Chandy, Nerea Jimenez-Tellez, Joseph C. Wu

    Cannabis has been consumed for centuries, but global regulatory changes over the past three decades have increased the availability and consumption of cannabis. Cannabinoids are touted to have therapeutic potential for many diseases and could be a replacement for opioids for analgesia and sedation. However, cannabinoids can cause substantial adverse cardiovascular events that would mitigate any potential benefit. The endocannabinoid system regulates mood, satiety and memory, and modulates the cardiovascular system. The link between cannabinoids and cardiovascular disease, which used to be limited to evidence from preclinical studies, case reports and case series, is now evident in epidemiological studies. Cannabinoids adversely affect the cardiovascular system, causing myocardial infarction, cerebrovascular accidents, arrhythmia and heart failure. The effects of novel cannabinoids are unknown, and synthetic cannabinoids have the potential to cause even more substantial harm than traditional cannabinoids. Therefore, with the increasing availability and use of cannabis, the acute and chronic effects of this drug are becoming apparent.


  • Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”

    by Mark Chandy, Thomas Hill, Nerea Jimenez-Tellez, Joseph C. Wu, S. Emma Sarles, Edward Hensel, Qixin Wang, Irfan Rahman, Daniel J. Conklin

    Cigarette smoking is positively and robustly associated with cardiovascular disease (CVD), including hypertension, atherosclerosis, cardiac arrhythmias, stroke, thromboembolism, myocardial infarctions, and heart failure. However, after more than a decade of ENDS presence in the U.S. marketplace, uncertainty persists regarding the long-term health consequences of ENDS use for CVD. New approach methods (NAMs) in the field of toxicology are being developed to enhance rapid prediction of human health hazards. Recent technical advances can now consider impact of biological factors such as sex and race/ethnicity, permitting application of NAMs findings to health equity and environmental justice issues. This has been the case for hazard assessments of drugs and environmental chemicals in areas such as cardiovascular, respiratory, and developmental toxicity. Despite these advances, a shortage of widely accepted methodologies to predict the impact of ENDS use on human health slows the application of regulatory oversight and the protection of public health. Minimizing the time between the emergence of risk (e.g., ENDS use) and the administration of well-founded regulatory policy requires thoughtful consideration of the currently available sources of data, their applicability to the prediction of health outcomes, and whether these available data streams are enough to support an actionable decision. This challenge forms the basis of this white paper on how best to reveal potential toxicities of ENDS use in the human cardiovascular system—a primary target of conventional tobacco smoking. We identify current approaches used to evaluate the impacts of tobacco on cardiovascular health, in particular emerging techniques that replace, reduce, and refine slower and more costly animal models with NAMs platforms that can be applied to tobacco regulatory science. The limitations of these emerging platforms are addressed, and systems biology approaches to close the knowledge gap between traditional models and NAMs are proposed. It is hoped that these suggestions and their adoption within the greater scientific community will result in fresh data streams that will support and enhance the scientific evaluation and subsequent decision-making of tobacco regulatory agencies worldwide. Graphical Abstract Models for Cardiovascular Toxicity Testing E-cigarettes and nicotine delivery systems can be examined using multiple model systems. In silico models might predict adverse cardiovascular effects that can be screened for using 2-D and 3-D models using induced pluripotent stem cell (iPSC) derived cardiac tissue and “omics” profiling such as single-cell RNA sequencing (scRNA-seq) or high-throughput functional analysis with a multiple electrode array (MEA). Biologic plausibility of detected effects can be corroborated using ex vivo or in vivo models, which may also lead to the discovery of new biomarkers or treatments for CVD.


  • Open Access

    Exploring the Impact of Partial Occlusion on Emotion Classification From Facial Expressions: A Comparative Study of XR Headsets and Face Masks

    by Alberto Casas-Ortiz, Jon Echeverria, Nerea Jimenez-Tellez, Olga C. Santos

    This study provides of a comparative analysis of emotion estimation from facial expressions under partial occlusion caused by face masks and extended reality (XR) headsets. Unlike previous studies that have independently explored these two scenarios, this research compares and analyzes the statistical differences between them. In order to achieve this, the RAF-DB dataset has been used as a non-occluded baseline to construct two new datasets: i) a dataset formed by faces partially occluded by face masks, and ii) a dataset formed by faces partially occluded by XR headsets. To evaluate the impact of occlusion in emotion estimation, three deep learning models have been fine-tuned using transfer learning, and results from a random classifier have been used as a baseline. Seven different metrics were obtained per dataset, and a 2-way ANOVA test was performed on each metric. As expected, significant statistical differences are observed between the non-occluded faces (acc. 0.8780) and the faces partially occluded by face masks (acc. 0.7520) and XR headsets (acc. 0.7400) on all metrics. Notably, the comparison between the two partially occluded datasets revealed significant statistical differences in the metrics f1-score (macro), precision (macro) and recall (macro), which we attribute to different types of occlusion affecting different parts of the face that are key to some emotions. This research contributes to advancing emotion recognition systems by highlighting their robustness and effectiveness even in partial occlusion settings, and showing a full comparative analysis between two common types of occlusion.


  • Open Access

    Sevoflurane Exposure in Neonates Perturbs the Expression Patterns of Specific Genes That May Underly the Observed Learning and Memory Deficits

    by Nerea Jimenez-Tellez, Marcus Pehar, Frank Visser, Alberto Casas-Ortiz, Tiffany Rice, Naweed I. Syed

    Exposure to commonly used anesthetics leads to neurotoxic effects in animal models—ranging from cell death to learning and memory deficits. These neurotoxic effects invoke a variety of molecular pathways, exerting either immediate or long-term effects at the cellular and behavioural levels. However, little is known about the gene expression changes following early neonatal exposure to these anesthetic agents. We report here on the effects of sevoflurane, a commonly used inhalational anesthetic, on learning and memory and identify a key set of genes that may likely be involved in the observed behavioural deficits. Specifically, we demonstrate that sevoflurane exposure in postnatal day 7 (P7) rat pups results in subtle, but distinct, memory deficits in the adult animals that have not been reported previously. Interestingly, when given intraperitoneally, pre-treatment with dexmedetomidine (DEX) could only prevent sevoflurane-induced anxiety in open field testing. To identify genes that may have been altered in the neonatal rats after sevoflurane and DEX exposure, specifically those impacting cellular viability, learning, and memory, we conducted an extensive Nanostring study examining over 770 genes. We found differential changes in the gene expression levels after exposure to both agents. A number of the perturbed genes found in this study have previously been implicated in synaptic transmission, plasticity, neurogenesis, apoptosis, myelination, and learning and memory. Our data thus demonstrate that subtle, albeit long-term, changes observed in an adult animal’s learning and memory after neonatal anesthetic exposure may likely involve perturbation of specific gene expression patterns.


  • Open Access

    Dexmedetomidine Pre-Treatment of Neonatal Rats Prevents Sevoflurane-Induced Deficits in Learning and Memory in the Adult Animals

    by Nerea Jimenez-Tellez, Marcus Pehar, Fahad Iqbal, Alberto Casas-Ortiz, Tiffany Rice, Naweed I. Syed

    Anesthetics have been shown to cause cytotoxicity, cell death, affect neuronal growth and connectivity in animal models; however, their effects on learning and memory remain to be fully defined. Here, we examined the effects of the inhalation anesthetic sevoflurane (SEV)—both in vivo by examining learning and memory in freely behaving animals, and in vitro using cultured neurons to assess its impact on viability, mitochondrial structure, and function. We demonstrate here that neonatal exposure to sub-clinically used concentrations of SEV results in significant, albeit subtle and previously unreported, learning and memory deficits in adult animals. These deficits involve neuronal cell death, as observed in cell culture, and are likely mediated through perturbed mitochondrial structure and function. Parenthetically, both behavioural deficits and cell death were prevented when the animals and cultured neurons were pre-treated with the anesthetic adjuvant Dexmedetomidine (DEX). Taken together, our data provide direct evidence for sevoflurane-induced cytotoxic effects at the neuronal level while perturbing learning and memory at the behavioural level. In addition, our data underscore the importance of adjuvant agents such as DEX that could potentially counter the harmful effects of commonly used anesthetic agents for better clinical outcomes.


  • Open Access

    Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants

    by Nerea Jimenez-Tellez, Carlos D. Vera, Zehra Yildirim, Julio Vicente Guevara, Tina Zhang, Joseph C. Wu


  • Open Access

    A synthetic peptide rescues rat cortical neurons from anesthetic-induced cell death and modulation of growth and synaptic assembly

    by Fahad Iqbal, Marcus Pehar, Andrew J. Thompson, Urva Azeem, Kiana Jahanbakhsh, Nerea Jimenez-Tellez, Rasha Sabouny, Shadab Batool, Atika Syeda, Jennifer Chow, et al.

    Anesthetics, although necessary for many modern procedures, exert neurotoxic effects in various experimental models; the underlying mechanisms, however, remain unknown. In the absence of this information, any in vivo mitigation strategy would be challenging. To help address these gaps, we sought to determine whether preserving mitochondrial network integrity with a non-toxic, short-life synthetic peptide, P110, could protect cortical neurons against both inhalational and intravenous anesthetic-induced neurotoxicity. This study provides the first direct comparative account of three key general anesthetics (desflurane, propofol, and ketamine) under identical conditions and demonstrates their impact on cellular viability, neurite outgrowth, and synaptic network assembly on neonatal rat cortical neurons. Further, we discovered that the inhibition of Fis1 receptor-mediated fission reverses anesthetic-induced aberrations in an agent-specific manner. Our data thus underscore the importance of a reductionist approach, offering unique opportunities to explore non-toxic, mitochondria-based therapeutic tools for mitigating anesthetic-induced harm to the developing brain.